We specifically hypothesized that increased HMGN1 dosage promotes global chromatin accessibility for transcription, thus leading to the derepression of PRC2 target genes, causatively linking the triplication of HMGN1 in trisomy to several DS-related cellular phenotypes. This evidence concerns the gene HMGN1 and Dravet syndrome.